WEDNESDAY, Feb. 17, 2021 (HealthDay News) — Higher levels of a certain type of immune cell may explain why immunotherapy for prostate cancer is more effective in Black men than in white men, researchers say. The finding could lead to immunotherapy-based precision treatment for localized aggressive and advanced prostate cancerContinue Reading

WEDNESDAY, Feb. 10, 2021 (HealthDay News) — If you have cancer and you’re trying to exercise to boost your health, new research suggests you don’t have to knock yourself out during your workout. Light exercise is just as beneficial as more demanding workouts for cancer patients, the researchers found. PreviousContinue Reading

TUESDAY, Feb. 9, 2021 (HealthDay News) — A new drug combination for advanced liver cancer can extend people’s lives substantially more than the long-standing drug of choice, new study findings confirm. The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV)Continue Reading

MONDAY, Feb. 8, 2021 (HealthDay News) — While scientists still don’t know what causes Parkinson’s disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness. A team led by scientists at the University ofContinue Reading

WEDNESDAY, Feb. 3, 2021 (HealthDay News) — Racial segregation may help explain why Black Americans with lung cancer do more poorly than their white counterparts, a new study suggests. For years, U.S. studies have documented racial disparities in lung cancer. Black Americans are less likely to receive surgery for early-stageContinue Reading